Background: Little is known about brain mechanisms supporting the experience of chronic puritus in disease states.

Objectives: To examine the difference in brain processing of histamine-induced itch in patients with active atopic dermatitis (AD) vs. healthy controls with the emerging technique of functional magnetic resonance imaging (fMRI) using arterial spin labelling (ASL).

Methods: Itch was induced with histamine iontophoresis in eight patients with AD and seven healthy subjects.

Results: We found significant differences in brain processing of histamine-induced itch between patients with AD and healthy subjects. Patients with AD exhibited bilateral activation of the anterior cingulate cortex (ACC), posterior cingulate cortex (PCC), retrosplenial cingulate cortex and dorsolateral prefrontal cortex (DLPFC) as well as contralateral activation of the caudate nucleus and putamen. In contrast, healthy subjects activated the primary motor cortex, primary somatosensory cortex and superior parietal lobe. The PCC and precuneus exhibited significantly greater activity in patients vs. healthy subjects. A significant correlation between percentage changes of brain activation was noted in the activation of the ACC and contralateral insula and histamine-induced itch intensity as well as disease severity in patients with AD. In addition, an association was noted between DLPFC activity and disease severity.

Conclusions: Our results demonstrate that ASL fMRI is a promising technique to assess brain activity in chronic itch. Brain activity of acute itch in AD seems to differ from that in healthy subjects. Moreover, the activity in cortical areas involved in affect and emotion correlated to measures of disease severity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784001PMC
http://dx.doi.org/10.1111/j.1365-2133.2009.09308.xDOI Listing

Publication Analysis

Top Keywords

histamine-induced itch
16
healthy subjects
16
brain activity
12
disease severity
12
patients healthy
12
cingulate cortex
12
itch
8
itch intensity
8
atopic dermatitis
8
brain processing
8

Similar Publications

Background: Pruritus significantly impacts quality of life, leading to increased interest in complementary and alternative medicines (CAMs) as potential treatments. This review explores the efficacy of various CAMs for pruritus.

Methods: A comprehensive review was conducted on the effectiveness of several CAMs for pruritus.

View Article and Find Full Text PDF

Chronic pruritis, characterized by persistent itchiness lasting more than six weeks, affects up to 15% of the population, significantly impairing quality of life. Despite its prevalence and impact, there is an absence of FDA-approved medications specifically for the treatment of chronic pruritus, highlighting a significant unmet need in dermatology. Advancements in dermatologic medications, however, including the development of biologics and Janus kinase (JAK) inhibitors, signal potential breakthroughs in pruritus management through a radically different mechanism of action that focuses on their effect on the nervous system.

View Article and Find Full Text PDF

Background: Photobiomodulation, also referred to as Low-Level Light Therapy (LLLT), has emerged as a promising intervention for pruritus, a prevalent and often distressing symptom.

Objectives: This study investigated the efficacy of low-level light therapy (LLLT) in alleviating pruritus, hyperknesis, and alloknesis induced by histamine and Mucuna pruriens.

Methods: In a double-blind, randomized, sham-controlled trial with a split-body design, healthy volunteers underwent 6 minutes of LLLT and sham treatments in separate upper back quadrants.

View Article and Find Full Text PDF

Spinal histamine H4 receptor mediates chronic pruritus via p-ERK in acetone-ether-water (AEW)-induced dry skin mice.

Exp Dermatol

July 2024

Department of Neurology and Neurological Rehabilitation, Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), Tongji University School of Medicine, Shanghai, China.

Dry skin is common to many pruritic diseases and is difficult to improve with oral traditional antihistamines. Recently, increasing evidence indicated that histamine H4 receptor (H4R) plays an important role in the occurrence and development of pruritus. Extracellular signal-regulated kinase (ERK) phosphorylation activation in the spinal cord mediates histamine-induced acute and choric itch.

View Article and Find Full Text PDF
Article Synopsis
  • TRPV3 is an ion channel that plays a role in skin physiology and itch, and inhibitors of this channel could help treat itching conditions.
  • Researchers isolated a compound from a medicinal plant called 14-deoxy-11,12-didehydroandrographolide (ddA), which inhibits TRPV3 and shows selectivity for this channel over others related to itch and inflammation.
  • In tests on mice, ddA reduced itch similar to the commonly used antihistamine loratadine, suggesting it could be a safe and effective alternative for treating itching.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!